SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-027587
Filing Date
2021-11-09
Accepted
2021-11-09 09:15:12
Documents
15
Period of Report
2021-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47000
2 ex10-1.htm EX-10.1 60893
3 ex99-1.htm EX-99.1 14076
4 ex99-1_001.jpg GRAPHIC 3069
  Complete submission text file 0001493152-21-027587.txt   317703

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pulm-20211108.xsd EX-101.SCH 3028
6 XBRL LABEL FILE pulm-20211108_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE pulm-20211108_pre.xml EX-101.PRE 22361
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3601
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 211390120
SIC: 2834 Pharmaceutical Preparations